Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910
Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine if a "Treat and Extend" regimen
(increasing the time between visits when the disease is stable and not getting worse) of
aflibercept 2.0mg injections inside the eye for treating patients with Wet Age-related
Macular Degeneration.